August 22, 2020
SHBT Faculty David Corey and Jeffrey Holt are featured in the Harvard Gazette’s recent article for their research on the TMC1 gene which opens doors for precision-targeted therapies to treat hearing loss.
See also: Home
SHBT Faculty David Corey and Jeffrey Holt are featured in the Harvard Gazette’s recent article for their research on the TMC1 gene which opens doors for precision-targeted therapies to treat hearing loss.